BIOGEN INC. Repayments of Bank Debt
BIOGEN INC. (BIIB) reported Repayments of Bank Debt of $3.20 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-10-24.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfBankDebt · last filed 2017-10-24
- 2017-09-30: Repayments of Bank Debt 9 month $3.20M.
- 2016-09-30: Repayments of Bank Debt 9 month $2.70M.
| Period end | Repayments of Bank Debt 9 month |
|---|---|
| 2017-09-30 | $3.20M 10-Q · filed 2017-10-24 |
| 2016-09-30 | $2.70M 10-Q · filed 2017-10-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |